pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

56 catalysts · 27 approval · 11 device pma · 10 device recall · 8 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-12-09×to 2025-12-09×clear all
type
  • approval27
  • device pma11
  • device recall10
  • device 510k8
therapy area

no tagged catalysts yet

Week of Dec 8, 2025

50
›
Dec 9, 2025
approval
263d ago
OXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Dec 9, 2025approval263d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

full page →fda approvals ↗
›Dec 9, 2025approval263d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

full page →fda approvals ↗
›Dec 9, 2025approval263d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

full page →fda approvals ↗
›Dec 9, 2025approval263d agoRYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approvalrozanolixizumab

Sponsor: UCB INC. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →rozanolixizumab →fda approvals ↗
›Dec 9, 2025approval263d agoIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalSUMATRIPTAN SUCCINATE

Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
›Dec 9, 2025approval263d agoRECARBRIO (CILASTATIN SODIUM) — FDA approval(cilastatin sodium + imipenem + relebactam)

Sponsor: MSD MERCK CO. Form: POWDER. Route: INTRAVENOUS

full page →(cilastatin sodium + imipenem + relebactam) →fda approvals ↗
›Dec 9, 2025approval263d agoTEPYLUTE (THIOTEPA) — FDA approvalSTI Pharma LLC

Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗
›Dec 9, 2025approval263d agoTEPYLUTE (THIOTEPA) — FDA approvalSTI Pharma LLC

Sponsor: SHORLA. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗
›Dec 9, 2025approval263d agoIMITREX (SUMATRIPTAN) — FDA approvalSUMATRIPTAN SUCCINATE

Sponsor: GLAXOSMITHKLINE. Form: SPRAY. Route: NASAL

full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
›Dec 9, 2025approval263d agoIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalSUMATRIPTAN SUCCINATE

Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
›Dec 9, 2025approval263d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗
›Dec 9, 2025approval263d agoVECURONIUM BROMIDE — FDA approvalVECURONIUM BROMIDE

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →VECURONIUM BROMIDE →fda approvals ↗
›Dec 9, 2025device 510k263d agoFocused Cryo, Inc. — Focused Cryotherapy System (510k cleared)

Product code: GEH. Advisory committee: General, Plastic Surgery. Type: Traditional

full page →fda device 510k ↗
›Dec 9, 2025device 510k263d agoGE Medical Systems SCS — Allia Moveo (510k cleared)

Product code: OWB. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗
›Dec 9, 2025device 510k263d agoShofu Dental Corporation — GlasIonomer FX-LC (510k cleared)

Product code: EMA. Advisory committee: Dental. Type: Traditional

full page →fda device 510k ↗
›Dec 9, 2025device 510k263d agoDevilbiss Healthcare, LLC — DeVilbiss PulmO2 10-Liter Oxygen Concentrator (1060AW) (510k cleared)

Product code: CAW. Advisory committee: Anesthesiology. Type: Traditional

full page →fda device 510k ↗
›Dec 9, 2025device 510k263d agoGuangzhou Longest Medical Technology Co., Ltd. — Portable Electro Stimulation Therapy Device (LGT-2320BE, LGT-2320ME, and LGT-2320SP) (510k cleared)Guangzhou Dazhou Biomedical Technology Co Ltd

Product code: NGX. Advisory committee: Physical Medicine. Type: Traditional

full page →fda device 510k ↗
›Dec 9, 2025device 510k263d agoTianjin Huahong Technology Co., Ltd. — Lancing device (HH-XV-T) (510k cleared)

Product code: QRL. Advisory committee: General, Plastic Surgery. Type: Special

full page →fda device 510k ↗
›Dec 9, 2025device 510k263d agoInfinitt Healthcare Co., Ltd. — INFINITT DPS (510k cleared)NVP Healthcare Co Ltd

Product code: QKQ. Advisory committee: Pathology. Type: Traditional

full page →fda device 510k ↗
›Dec 9, 2025device 510k263d agoDentsply Sirona — Atlantis® Abutments in Titanium (510k cleared)DENTSPLY SIRONA Inc.

Product code: NHA. Advisory committee: Dental. Type: Traditional

full page →fda device 510k ↗
›Dec 9, 2025device pma263d agoAbbott Vascular, Inc. — XACT® Carotid Stent System (PMA supplement)

Supplement type: Normal 180 Day Track No User Fee. Product code: NIM. Advisory committee: CV. Decision: APPR

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoZoll Manufacturing Corporation — LifeVest® Wearable Defibrillator (PMA supplement)

Supplement type: Real-Time Process. Product code: MVK. Advisory committee: CV. Decision: APPR

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoDepuy, Inc. — LCS® Total Knee System (PMA supplement)

Supplement type: 30-Day Notice. Product code: NJL. Advisory committee: OR. Decision: OK30

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoAbbott Vascular, Inc. — Perclose ProGlide® Suture-Mediated Closure System; Prostar® XL Percutaneous Vascular Surgical System (PMA supplement)

Supplement type: Normal 180 Day Track No User Fee. Product code: MGB. Advisory committee: CV. Decision: APPR

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoZOLL Medical Corporation — ZOLL Zenix Monitor/Defibrillator; ZOLL Zenix Multi-function Cable; ZOLL Zenix CPR Complete Electrodes; ZOLL OneStep Paci (PMA supplement)

Supplement type: Real-Time Process. Product code: MKJ. Advisory committee: CV. Decision: APPR

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoDePuy Orthopaedics, Inc. — Ceramax Ceramic Hip System (PMA supplement)

Supplement type: 30-Day Notice. Product code: MRA. Advisory committee: OR. Decision: OK30

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoAbbott Vascular Devices — StarClose SE® Vascular Surgical System (PMA supplement)

Supplement type: Normal 180 Day Track No User Fee. Product code: MGB. Advisory committee: CV. Decision: APPR

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoABBOTT MEDICAL — Tendril STS Leads; Ultipace Leads (PMA supplement)

Supplement type: 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoABBOTT MEDICAL — Durata Leads; Optisure Leads (PMA supplement)

Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoProverum, Ltd. — ProVee System for BPH (PMA)

Product code: MER. Advisory committee: GU. Decision: APPR

full page →fda device pma ↗
›Dec 9, 2025device pma263d agoAbbott Vascular (Idef Technologies Inc) — Supera™ Peripheral Stent System (PMA supplement)

Supplement type: Normal 180 Day Track No User Fee. Product code: NIP. Advisory committee: CV. Decision: APPR

full page →fda device pma ↗
›Dec 9, 2025device recall263d agoIntuitive Surgical, Inc. device recall (Cls II)INTUITIVE SURGICAL INC

Brand Name: da Vinci S, Si Permanent Cautery Hook Instrument Product Name: da Vinci S, Si Permanent Cautery Hook Instrument Model/Catalog Number: 420183 Software Version: NA Product Description: EndoWrist Instruments or da Vinci S/Si Reusable instruments, including blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pick-ups, needle holders, endoscopic retractors, electrocautery and accessories are intended for endoscopic manipulation of tissue, including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, and delivery and placement of microwave and cryogenic ablation probes and accessories. Please refer to attached User Manual for additional details on intended use. All da Vinci S/Si reusable instruments with jaws use mechanical tungsten cables and pulleys to transmit motion from the input discs to the housing (on the proximal chassis), through the main shaft, and the distal instrument tip (inside the patient). Component: NA — Reason: Due to increased in complaints regarding frayed or broken pitch cables on reusable surgical instruments — Status: Ongoing

full page →fda device recalls ↗
›Dec 9, 2025device recall263d agoIntuitive Surgical, Inc. device recall (Cls II)INTUITIVE SURGICAL INC

Brand Name: da Vinci S, Si Mega Needle Driver Instrument Product Name: da Vinci S, Si Mega Needle Driver Instrument Model/Catalog Number: 420194 Software Version: NA Product Description: EndoWrist Instruments or Da Vinci S/Si Reusable instruments, including blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pick-ups, needle holders, endoscopic retractors, electrocautery and accessories are intended for endoscopic manipulation of tissue, including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, and delivery and placement of microwave and cryogenic ablation probes and accessories. Please refer to attached User Manual for additional details on intended use. All da Vinci S/Si reusable instruments with jaws use mechanical tungsten cables and pulleys to transmit motion from the input discs to the housing (on the proximal chassis), through the main shaft, and the distal instrument tip (inside the patient). Component: NA — Reason: Due to increased complaints for broken/frayed grip cables for reusable instruments. — Status: Ongoing

full page →fda device recalls ↗
›Dec 9, 2025device recall263d agoHeraeus Medical GmbH (Dental Division) device recall (Cls II)

Brand Name: PALACOS Product Name: PALACOS R+G pro 40; PALACOS R+G pro 80 Model/Catalog Number: 5081288; 5081289 Software Version: N/A Product Description: Radiopaque, poly(methyl methacrylate)-based (PMMA) bone cement, pre-filled into a mixing and application system, suitable for use with or without vacuum (ready to mix). Component: N/A — Reason: increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule breakage. An unfortunate combination of these influence factors can lead to unbreakable ampoules. If none or not all ampoules break, the product cannot be used on the patient since no or no appropriate cement dough is formed. — Status: Ongoing

full page →fda device recalls ↗
›Dec 9, 2025device recall263d agoIntuitive Surgical, Inc. device recall (Cls II)INTUITIVE SURGICAL INC

Brand Name: da Vinci S, Si Grasping Retractor Instrument Product Name: da Vinci S, Si Grasping Retractor Instrument Model/Catalog Number: 420278 Software Version: NA Product Description: EndoWrist Instruments or Da Vinci S/Si Reusable instruments, including blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pick-ups, needle holders, endoscopic retractors, electrocautery and accessories are intended for endoscopic manipulation of tissue, including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, and delivery and placement of microwave and cryogenic ablation probes and accessories. Please refer to attached User Manual for additional details on intended use. All da Vinci S/Si reusable instruments with jaws use mechanical tungsten cables and pulleys to transmit motion from the input discs to the housing (on the proximal chassis), through the main shaft, and the distal instrument tip (inside the patient). Component: NA — Reason: Due to increased complaints for broken/frayed grip cables for reusable instruments. — Status: Ongoing

full page →fda device recalls ↗
← prev
page 1 of 2
next →
$ONC372.61-0.85%
$ANIP73.85-0.95%
$ANIP73.85-0.95%
$AMRX17.54-2.61%
$AMRX17.54-2.61%
$ANIP73.85-0.95%
$ANIP73.85-0.95%
$AMRX17.54-2.61%
$AMRX17.54-2.61%
$AMRX17.54-2.61%
$ONC372.61-0.85%
$ONC372.61-0.85%
$XRAY11.12+0.72%
$MRK153.10-2.14%
$ISRG372.60+1.51%
$ISRG372.60+1.51%
$ISRG372.60+1.51%